Target intelligence / Profile preview

S-phase cancer associated transcript 8 (SCAT8)

Target
SCAT8
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

S-phase cancer associated transcript 8 (SCAT8), also referred to as EYS-AS1 or EYS antisense RNA 1, is a long non-coding RNA gene (Entrez Gene ID: 112935969, Ensembl: ENSG00000236345) located on chromosome 6q12. It is annotated as a non-coding RNA (lncRNA) that was initially identified in association with S-phase cancer, but its precise biological function, molecular mechanism, or disease involvement remains largely uncharacterized. No evidence currently supports its role as a direct therapeutic target. There is no information about clinical significance, associated disease phenotypes, or interaction with therapeutics. SCAT8 does not encode a protein or function as a classic therapeutic target such as a receptor, enzyme, or transporter. Its primary characterization comes from sequence-based annotation and proposed associations with cancer, though without functional validation. No alias or synonym suggests a connection to other well-characterized targets. All entries indicate absence of biomarker utility, lack of drug interactions, and lack of recognized therapeutic relevance or safety concerns.

Other names
EYS-AS1EYS antisense RNA 1SCAT8
02

Mechanism of action

Not defined; no known mechanism of action for drug targeting, as no drugs target SCAT8

03

Biological functions

Unknown or poorly characterized; initially proposed to be associated with S-phase cancer, suggesting a possible role in cell cycle regulation
04

Disease associations

Cancer (proposed/putative, not validated or well characterized)

Beyond the preview

Go deeper on S-phase cancer associated transcript 8 (SCAT8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-phase cancer associated transcript 8 (SCAT8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call